Experimental Therapy Extends Cancer Patients’ Lives by 40% in Clinical Trial
A cutting-edge treatment aimed at combating some of the most aggressive forms of stomach cancer has shown encouraging results in a phase 2 clinical trial, offering significant tumor reduction and extended survival times. Harnessing the Body’s Own Defenses The approach uses a type of CAR T cell immunotherapy, in which a patient’s own immune cells […]
Experimental Therapy Extends Cancer Patients’ Lives by 40% in Clinical Trial Read More »









